Graegis Pharmaceuticals Limited

DataGardener
live
Small

Graegis Pharmaceuticals Limited

13680871Private Limited With Share Capital

C/O The Cambridge Partnership, The Dorothy Hodgkin Building, Cambridge, CB223FH
Incorporated

14/10/2021

Company Age

4 years

Directors

2

Employees

SIC Code

72110

Risk

moderate risk

Company Overview

Registration, classification & business activity

Graegis Pharmaceuticals Limited (13680871) is a private limited with share capital incorporated on 14/10/2021 (4 years old) and registered in cambridge, CB223FH. The company operates under SIC code 72110 - research and experimental development on biotechnology.

Private Limited With Share Capital
SIC: 72110
Small
Incorporated 14/10/2021
CB223FH

Financial Overview

Total Assets

£3.03M

Liabilities

£395.4K

Net Assets

£2.64M

Cash

£2.94M

Key Metrics

2

Directors

1

Shareholders

Board of Directors

1

Filed Documents

37
Accounts With Accounts Type Small
Category:Accounts
Date:24-04-2026
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:17-10-2025
Accounts With Accounts Type Small
Category:Accounts
Date:11-06-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:15-10-2024
Accounts With Accounts Type Small
Category:Accounts
Date:09-10-2024
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:06-11-2023
Memorandum Articles
Category:Incorporation
Date:06-11-2023
Resolution
Category:Resolution
Date:06-11-2023
Capital Name Of Class Of Shares
Category:Capital
Date:06-11-2023
Capital Name Of Class Of Shares
Category:Capital
Date:06-11-2023
Change Account Reference Date Company Current Extended
Category:Accounts
Date:27-10-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:27-10-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:27-10-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:27-10-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:27-10-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:27-10-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:13-10-2023
Capital Allotment Shares
Category:Capital
Date:12-09-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:12-09-2023
Accounts With Accounts Type Small
Category:Accounts
Date:24-07-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:11-05-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:12-12-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:12-12-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:25-10-2022
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:14-09-2022
Second Filing Capital Allotment Shares
Category:Capital
Date:31-01-2022
Capital Allotment Shares
Category:Capital
Date:21-01-2022
Capital Name Of Class Of Shares
Category:Capital
Date:18-01-2022
Resolution
Category:Resolution
Date:18-12-2021
Memorandum Articles
Category:Incorporation
Date:18-12-2021
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:08-12-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:08-12-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:08-12-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:08-12-2021
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:08-12-2021
Appoint Corporate Secretary Company With Name Date
Category:Officers
Date:29-10-2021
Incorporation Company
Category:Incorporation
Date:14-10-2021

Risk Assessment

moderate risk

International Score

Future Factor

excellent

Performance Rating

Accounts

Typesmall company
Due Date30/09/2026
Filing Date06/06/2025
Latest Accounts31/12/2024

Trading Addresses

The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, CB223FHRegistered

Contact

C/O The Cambridge Partnership, The Dorothy Hodgkin Building, Cambridge, CB223FH